Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas.

Duchatel RJ, Savary C, Germon ZP, Riley M, Ziegler DS, Mueller S, Jackson ER, Dun MD

Open source

DOI
10.1093/neuonc/noaf163
Published
2025 Nov 1
Container
Neuro-oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noaf163,
  title = {Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas.},
  author = {Duchatel RJ and Savary C and Germon ZP and Riley M and Ziegler DS and Mueller S and Jackson ER and Dun MD},
  year = {2025},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noaf163},
  url = {https://doi.org/10.1093/neuonc/noaf163}
}

RIS

TY  - JOUR
TI  - Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas.
AU  - Duchatel RJ
AU  - Savary C
AU  - Germon ZP
AU  - Riley M
AU  - Ziegler DS
AU  - Mueller S
AU  - Jackson ER
AU  - Dun MD
PY  - 2025
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noaf163
UR  - https://doi.org/10.1093/neuonc/noaf163
ER  - 

APA

RJ, D., C, S., ZP, G., M, R., DS, Z., S, M., ER, J., & MD, D. (2025). Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas.. Neuro-oncology. https://doi.org/10.1093/neuonc/noaf163

Source records